Barclays Maintains Overweight on GoodRx Holdings, Lowers Price Target to $9
Barclays analyst Ross Sandler maintains GoodRx Holdings (NASDAQ:GDRX) with a Overweight and lowers the price target from $13 to $9.
Stocks That Hit 52-Week Lows On Monday
During Monday's session, 402 companies made new 52-week lows.
Keybanc Initiates Coverage On GoodRx Holdings with Sector Weight Rating
Keybanc analyst Scott Schoenhaus initiates coverage on GoodRx Holdings (NASDAQ:GDRX) with a Sector Weight rating.
Looking Into GoodRx Holdings’s Return On Capital Employed
GoodRx Holdings (NASDAQ:GDRX) brought in sales totaling $191.80 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 111.51%, resulting in a loss of $1.42 million.
WeTrade, Roblox And Some Other Big Stocks Moving Lower On Wednesday
OptimizeRx Corporation (NASDAQ: OPRX) shares fell 26.7% to $16.32 after the company reported worse-than-expected Q2 EPS and sales results and issued FY22 sales guidance below estimates.
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The company also reported Q2 earnings results.
Qualys, ShockWave Medical, News Corporation And Some Other Big Stocks Moving Higher On Tuesday
Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The company also reported Q2 earnings results.
Why Is BIMI International Medical Higher By Around 70%: Here Are 38 Stocks Moving Premarket
Gainers
BIMI International Medical Inc. (NASDAQ: BIMI) shares rose 69.6% to $1.04 in pre-market trading after Fnu Oudom reported a stake of 44% in the company in 13D.